137 related articles for article (PubMed ID: 37011813)
1. Host and primary tumor factors for the development of multiple cutaneous squamous cell carcinomas among a retrospective cohort in Rhode Island.
Moseley I; Ahmed F; Lin E; Lim R; Hoang M; Baranwal N; Robinson-Bostom L; Libby T; Wisco O; Qureshi A; Cho E
J Am Acad Dermatol; 2023 Sep; 89(3):511-518. PubMed ID: 37011813
[TBL] [Abstract][Full Text] [Related]
2. Risk factors and timing of subsequent cutaneous squamous cell carcinoma in patients with cutaneous squamous cell carcinoma: A retrospective cohort study.
Rodriguez M; Beal BT; Manmohan M; Simmons E; Varra V; Xiong D; Eversman A; Briskin IN; Knackstedt T; Vidimos AT
J Am Acad Dermatol; 2021 Mar; 84(3):719-724. PubMed ID: 32861709
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
4. Cumulative incidence and timing of subsequent cutaneous squamous cell carcinomas stratified for patients with organ transplantation and hematologic malignancies: A nationwide cohort study.
Eggermont CJ; Hollestein LM; Hollatz A; Louwman M; Mooyaart AL; Nijsten T; Wakkee M
J Am Acad Dermatol; 2024 Mar; 90(3):530-536. PubMed ID: 37871807
[TBL] [Abstract][Full Text] [Related]
5. Association of Age, Sex, Race, and Geographic Region With Variation of the Ratio of Basal Cell to Cutaneous Squamous Cell Carcinomas in the United States.
Lukowiak TM; Aizman L; Perz A; Miller CJ; Sobanko JF; Shin TM; Giordano CN; Higgins HW; Etzkorn JR
JAMA Dermatol; 2020 Nov; 156(11):1192-1198. PubMed ID: 32845319
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors and Prognosis for Metastatic Cutaneous Squamous Cell Carcinoma: A Cohort Study.
Knuutila JS; Riihilä P; Kurki S; Nissinen L; Kähäri VM
Acta Derm Venereol; 2020 Sep; 100(16):adv00266. PubMed ID: 32930344
[TBL] [Abstract][Full Text] [Related]
7. Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.
Tokez S; Hollestein L; Louwman M; Nijsten T; Wakkee M
JAMA Dermatol; 2020 Dec; 156(12):1300-1306. PubMed ID: 33112377
[TBL] [Abstract][Full Text] [Related]
8. Ten-Year Follow-up of Persons With Sun-Damaged Skin Associated With Subsequent Development of Cutaneous Squamous Cell Carcinoma.
Madani S; Marwaha S; Dusendang JR; Alexeeff S; Pham N; Chen EH; Han S; Herrinton LJ
JAMA Dermatol; 2021 May; 157(5):559-565. PubMed ID: 33760003
[TBL] [Abstract][Full Text] [Related]
9. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
10. Rates of Second Tumor, Metastasis, and Death From Cutaneous Squamous Cell Carcinoma in Patients With and Without Transplant-Associated Immunosuppression.
Gjersvik P; Falk RS; Roscher I; Rizvi SMH; Mjøen G; Gude E; Leuckfeld I; Boberg KM; Veierød MB; Robsahm TE
JAMA Dermatol; 2023 Sep; 159(9):923-929. PubMed ID: 37466985
[TBL] [Abstract][Full Text] [Related]
11. Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Ahmady S; Jansen MHE; Nelemans PJ; Kessels JPHM; Arits AHMM; de Rooij MJM; Essers BAB; Quaedvlieg PJF; Kelleners-Smeets NWJ; Mosterd K
JAMA Dermatol; 2022 Jun; 158(6):634-640. PubMed ID: 35475852
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
14. Nonmelanoma skin cancer mortality (1988-2000): the Rhode Island follow-back study.
Lewis KG; Weinstock MA
Arch Dermatol; 2004 Jul; 140(7):837-42. PubMed ID: 15262694
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of Patients Hospitalized for Cutaneous Squamous Cell Carcinoma.
Tripathi R; Knusel KD; Ezaldein HH; Bordeaux JS; Scott JF
Dermatol Surg; 2020 Jun; 46(6):742-746. PubMed ID: 31490307
[TBL] [Abstract][Full Text] [Related]
16. Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.
Kim YS; Jung SH; Park YM; Park GS; Kim HS; Maeng LS; Chung YJ
Exp Dermatol; 2023 Apr; 32(4):447-456. PubMed ID: 36533870
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the utility of localized adjuvant radiation for node-negative primary cutaneous squamous cell carcinoma with clear histologic margins.
Ruiz ES; Koyfman SA; Que SKT; Kass J; Schmults CD
J Am Acad Dermatol; 2020 Feb; 82(2):420-429. PubMed ID: 31349042
[TBL] [Abstract][Full Text] [Related]
18. Premalignant lesions, basal cell carcinoma and melanoma in patients with cutaneous squamous cell carcinoma.
Korhonen N; Ylitalo L; Luukkaala T; Itkonen J; Häihälä H; Jernman J; Snellman E; Palve J
Arch Dermatol Res; 2021 Dec; 313(10):879-884. PubMed ID: 32772261
[TBL] [Abstract][Full Text] [Related]
19. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
20. HLA expression as a risk factor for metastases of cutaneous squamous-cell carcinoma in organ- transplant recipients.
de Jong E; Quint KD; El Ghalbzouri A; Verdijk RM; Goeman JJ; Heidt S; Claas FHJ; de Fijter JW; Genders RE; Vermeer MH; Bouwes Bavinck JN
Hum Immunol; 2023 Mar; 84(3):208-213. PubMed ID: 36621381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
